BE2018C032I2 - - Google Patents

Info

Publication number
BE2018C032I2
BE2018C032I2 BE2018C032C BE2018C032C BE2018C032I2 BE 2018C032 I2 BE2018C032 I2 BE 2018C032I2 BE 2018C032 C BE2018C032 C BE 2018C032C BE 2018C032 C BE2018C032 C BE 2018C032C BE 2018C032 I2 BE2018C032 I2 BE 2018C032I2
Authority
BE
Belgium
Application number
BE2018C032C
Other languages
French (fr)
Original Assignee
Biocryst Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharm Inc filed Critical Biocryst Pharm Inc
Publication of BE2018C032I2 publication Critical patent/BE2018C032I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C07C247/14—Compounds containing azido groups with azido groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
BE2018C032C 1997-12-17 2018-09-04 BE2018C032I2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6995697P 1997-12-17 1997-12-17
US8525298P 1998-05-13 1998-05-13
PCT/US1998/026871 WO1999033781A1 (en) 1997-12-17 1998-12-17 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors

Publications (1)

Publication Number Publication Date
BE2018C032I2 true BE2018C032I2 (ja) 2018-10-15

Family

ID=26750600

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2018C032C BE2018C032I2 (ja) 1997-12-17 2018-09-04

Country Status (28)

Country Link
US (1) US6562861B1 (ja)
EP (1) EP1040094B9 (ja)
JP (3) JP4102022B2 (ja)
KR (1) KR20010024743A (ja)
CN (1) CN1282316A (ja)
AR (1) AR016162A1 (ja)
AT (1) ATE425955T1 (ja)
AU (1) AU2200199A (ja)
BE (1) BE2018C032I2 (ja)
BR (1) BR9813480A (ja)
CA (1) CA2315262C (ja)
CY (2) CY1109153T1 (ja)
DE (1) DE69840674D1 (ja)
DK (1) DK1040094T3 (ja)
ES (1) ES2324746T3 (ja)
FR (1) FR18C1037I2 (ja)
HU (1) HUP0100142A3 (ja)
IL (1) IL136812A0 (ja)
LT (1) LTC1040094I2 (ja)
NL (1) NL300952I2 (ja)
NO (1) NO20003084L (ja)
PL (1) PL196674B1 (ja)
PT (1) PT1040094E (ja)
RO (1) RO121815B1 (ja)
SI (1) SI1040094T1 (ja)
SK (1) SK8712000A3 (ja)
WO (1) WO1999033781A1 (ja)
ZA (1) ZA9811595B (ja)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE322163T1 (de) 1996-06-14 2006-04-15 Biocryst Pharm Inc Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind
SI1040094T1 (sl) * 1997-12-17 2009-10-31 Biocryst Pharm Inc Substituirane ciklopentanske in ciklopentenske spojine, uporabne kot inhibitorji nevraminidaze
US6518305B1 (en) * 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US6455571B1 (en) * 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
JP2002521312A (ja) * 1998-04-23 2002-07-16 アボット・ラボラトリーズ ノイラミニダーゼの阻害剤
WO2000028328A1 (en) 1998-11-05 2000-05-18 Biocryst Pharmaceuticals, Inc. New cyclopentane and cyclopentene compounds and use for detecting influenza virus
HUP0202097A2 (en) * 1999-06-28 2002-10-28 Biocryst Pharm Inc Process for preparing substituted cyclopentane derivatives and novel crystalline form of these derivatives
US6762316B1 (en) * 1999-06-28 2004-07-13 Biocryst Pharmaceuticals, Inc. Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates
AU5479700A (en) * 1999-06-28 2001-01-31 Biocryst Pharmaceuticals, Inc. Process for preparing (-)-(1s,4r) n-protected 4-amino-2-cyclopentene-1-carboxylate esters
AR024600A1 (es) * 1999-06-28 2002-10-16 Biocryst Pharm Inc Preparacion de compuestos de ciclopentano y ciclopenteno sustituidos y ciertos intermediarios
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
US6627396B1 (en) 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
AU2001243253A1 (en) * 2000-02-24 2001-09-03 Biocryst Pharmaceuticals, Inc. Prodrugs of substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
DE60136530D1 (de) * 2000-03-01 2008-12-24 Janssen Pharmaceutica Nv 2,4-disubstituierte thiazolyl derivate
WO2001080892A1 (fr) * 2000-04-25 2001-11-01 Sankyo Company, Limited Substances preventives de la grippe
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
EP1334969A4 (en) * 2000-10-18 2005-08-24 Kuraray Co PREPARATION OF 4-N SUBSTITUTED AMINO-2-AZA-1-OXYBICYCLO 3.3.0] OCT-2-ENE-6-CARBOXYLIC ACID ESTERS AND PREPARATION OF THEIR INTERMEDIATE PRODUCTS
WO2002092555A1 (fr) * 2001-05-11 2002-11-21 Sankyo Company, Limited Derives d'acides sialiques
ES2401285T3 (es) 2004-12-16 2013-04-18 The Regents Of The University Of California Fármacos con el pulmón como diana
WO2007087056A2 (en) * 2006-01-13 2007-08-02 Scolr Pharma, Inc. Peramivir derivative for oral administration
EP1986626A1 (en) * 2006-02-13 2008-11-05 Biocryst Pharmaceuticals Inc. Intravenous antiviral treatments
US20070203241A1 (en) 2006-02-13 2007-08-30 Babu Yarlagadda S Antiviral treatments
EA200870430A1 (ru) * 2006-04-12 2009-06-30 Байокрист Фармасьютикалз, Инк. Внутримышечные антивирусные способы лечения
US20070244193A1 (en) * 2006-04-12 2007-10-18 Babu Yarlagadda S Intramuscular antiviral treatments
CN100432047C (zh) * 2006-07-03 2008-11-12 华南农业大学 一种抗流感及禽流感病毒药物帕拉米韦的合成方法
US8227425B2 (en) 2007-01-23 2012-07-24 Therapicon Srl Antiviral compounds
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
ES2655028T3 (es) 2007-08-02 2018-02-16 Millennium Pharmaceuticals, Inc. Proceso para la síntesis de inhibidores de enzima de activación de E1
CN101367750B (zh) * 2007-08-14 2012-05-23 中国人民解放军军事医学科学院毒物药物研究所 (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途
AU2014200052B2 (en) * 2007-11-05 2016-01-07 Ala Wai Pharma, Inc. Formulations for enhanced bioavailability of orally administered polar agents
CA2704778C (en) * 2007-11-05 2014-04-29 Scolr Pharma, Inc. Formulations for enhanced bioavailability of orally administered polar agents
CN101538228B (zh) * 2008-03-21 2012-05-30 北京普世康医药技术有限公司 抗流感和禽流感病毒药物化合物帕拉米韦的合成方法
CN101486664B (zh) * 2008-12-31 2013-09-04 北京大学深圳研究生院 用作流感病毒神经氨酸酶抑制剂的多取代五元环小分子化合物
EP2429991B1 (en) 2009-05-15 2014-09-10 Redx Pharma Limited Redox drug derivatives
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
WO2011150205A2 (en) 2010-05-27 2011-12-01 Dr. Reddy's Laboratories Ltd. Highly selective asymmetric hydroformylation of (1s,4r) or (1r,4s)-2-azabicyclo[2.2.1]hept-5-en-3- one (+) or (-)-lactam
CN102584637B (zh) * 2011-01-17 2014-07-09 天津药物研究院 帕拉米韦水合物晶体、制备方法、药用组合物及其用途
CN102603577A (zh) * 2011-01-19 2012-07-25 董慧珍 一种抗流感和禽流感药物的衍生物及其用途
CN103827082B (zh) * 2011-04-29 2016-01-20 上海泓博智源医药技术有限公司 一种制备帕拉米韦及其中间体的新工艺
CN102757365B (zh) * 2011-04-29 2013-10-30 上海泓博智源医药技术有限公司 一种制备帕拉米韦关键中间体的方法
CN102964267B (zh) * 2011-09-01 2015-06-10 中山大学 一种具有流感病毒神经氨酸酶抑制活性的环己烯化合物及其制备方法以及其应用
CN102863359B (zh) * 2012-05-16 2014-05-07 常州制药厂有限公司 一种抗流感药物的合成方法
CN102702033A (zh) * 2012-06-11 2012-10-03 天津泰普药品科技发展有限公司 无定型帕拉米韦及其制备方法与药物组合物
WO2014068265A1 (en) 2012-10-29 2014-05-08 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
WO2014143643A1 (en) 2013-03-15 2014-09-18 The Regents Of The University Of California, A California Corporation Acyclic nucleoside phosphonate diesters
AU2014265483B2 (en) 2013-05-14 2018-08-02 Biocryst Pharmaceuticals, Inc. Anti-influenza compositions and methods
CN105294589B (zh) * 2014-06-18 2017-06-30 朱靖华 一种抗病毒药物及其制备方法
KR102589658B1 (ko) 2014-09-15 2023-10-13 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 뉴클레오타이드 유사체
CN104387288B (zh) * 2014-11-25 2016-04-20 广东东阳光药业有限公司 作为神经氨酸酶抑制剂的化合物及其在药物中的应用
CN104496838B (zh) * 2014-12-03 2016-04-20 广东东阳光药业有限公司 取代环丁烷类神经氨酸酶抑制剂及其使用方法和用途
CN104496839B (zh) * 2014-12-03 2016-04-20 广东东阳光药业有限公司 取代环丁烷类神经氨酸酶抑制剂及其使用方法和用途
CN104496857B (zh) * 2014-12-10 2016-10-12 广东东阳光药业有限公司 作为神经氨酸酶抑制剂的化合物及其在药物中的应用
CN105198827A (zh) * 2015-04-13 2015-12-30 广州南新制药有限公司 一种帕拉米韦中间体的合成方法
EA035650B1 (ru) * 2015-08-10 2020-07-21 Алжеон, Инк. Композиции и способы лечения и предотвращения нейродегенеративных расстройств
CN106220515A (zh) * 2016-08-12 2016-12-14 郸城巨鑫生物科技有限公司 一种(1r,4s)‑1‑氨基‑4‑羟甲基‑2‑环戊烯盐酸盐的合成方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT979736B (it) 1972-03-07 1974-09-30 Ethyl Corp Detersivo contenente un sequestran te e relativo metodo di impiego
US4089897A (en) * 1976-05-10 1978-05-16 Minnesota Mining And Manufacturing Company Geminal prostaglandin analogs
US4426391A (en) 1982-09-15 1984-01-17 Merck & Co., Inc. [(Alkoxycarbonyl)oxy]alkyl esters of methyldopa
JPS59163365A (ja) 1983-03-08 1984-09-14 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物
EP0130119B1 (en) 1983-06-23 1988-11-09 Merck & Co. Inc. (acyloxyalkoxy) carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs, their preparation and pharmaceutical compositions containing said derivatives
ZA878096B (en) * 1986-11-03 1988-04-26 Merrell Dow Pharmaceuticals Inc. Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds
JPS63179835A (ja) 1986-12-20 1988-07-23 メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング シクロペンタン誘導体
ES2075429T3 (es) * 1990-02-02 1995-10-01 Schering Corp Derivados de 4,5-cicloalcano-3-benzazepin-7-ol y sus usos.
AU1566192A (en) 1991-03-12 1992-10-21 Mect Corporation Synthesis of sialic acid and synthetic intermediate therefor
JP2951765B2 (ja) 1991-09-10 1999-09-20 三共株式会社 エナミノエステル類およびその製法
AU673824B2 (en) * 1992-05-29 1996-11-28 Bayer Aktiengesellschaft Cyclopentane- and -pentene-beta-amino acids
JPH07145120A (ja) * 1993-11-25 1995-06-06 Kuraray Co Ltd ｃｉｓ−４−アミノ−２−シクロペンテン−１−カルボン酸の製造法
EP0746564B1 (en) * 1994-02-25 1998-12-02 E.I. Du Pont De Nemours And Company 4-n-substituted sialic acids and their sialosides
US5453533A (en) * 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
US5789434A (en) 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
DE10299052I1 (de) * 1995-02-27 2003-05-22 Gilead Sciences Inc Neue selektive Inhibitoren viraler oder bakterieller Neuraminidasen
CA2176414A1 (en) 1995-05-18 1996-11-19 S. David Kimball Acyl guanidine and amidine prodrugs
US5990156A (en) * 1995-05-19 1999-11-23 Biota Scientific Management Pty Ltd. 6-Carboxamido dihydropyran derivatives
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
ATE322163T1 (de) * 1996-06-14 2006-04-15 Biocryst Pharm Inc Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind
CA2279927A1 (en) 1997-02-06 1998-08-13 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
KR20010024123A (ko) * 1997-09-17 2001-03-26 헨슬레이 맥스 디. 6-원 고리를 갖는 화합물, 그의 제조 방법 및의약물로서의 용도
SI1040094T1 (sl) * 1997-12-17 2009-10-31 Biocryst Pharm Inc Substituirane ciklopentanske in ciklopentenske spojine, uporabne kot inhibitorji nevraminidaze
JP2002521312A (ja) 1998-04-23 2002-07-16 アボット・ラボラトリーズ ノイラミニダーゼの阻害剤
SK15092000A3 (sk) 1998-04-23 2001-05-10 Abbott Laboratories Pyrolidíny ako inhibítory neuraminidáz

Also Published As

Publication number Publication date
CA2315262A1 (en) 1999-07-08
SK8712000A3 (en) 2000-11-07
NO20003084L (no) 2000-08-14
EP1040094B1 (en) 2009-03-18
WO1999033781A1 (en) 1999-07-08
CN1282316A (zh) 2001-01-31
EP1040094A4 (en) 2004-12-08
FR18C1037I2 (fr) 2019-06-21
LTC1040094I2 (lt) 2018-11-26
FR18C1037I1 (fr) 2018-12-10
JP5118502B2 (ja) 2013-01-16
ES2324746T3 (es) 2009-08-13
IL136812A0 (en) 2001-06-14
JP2011256196A (ja) 2011-12-22
DK1040094T3 (da) 2009-06-02
LTPA2018513I1 (lt) 2018-10-10
RO121815B1 (ro) 2008-05-30
EP1040094A1 (en) 2000-10-04
HUP0100142A2 (hu) 2001-05-28
BR9813480A (pt) 2000-10-10
JP2008163035A (ja) 2008-07-17
JP5709688B2 (ja) 2015-04-30
CA2315262C (en) 2009-11-10
SI1040094T1 (sl) 2009-10-31
HUP0100142A3 (en) 2002-01-28
AR016162A1 (es) 2001-06-20
JP4102022B2 (ja) 2008-06-18
PL196674B1 (pl) 2008-01-31
JP2001527058A (ja) 2001-12-25
NL300952I2 (nl) 2018-09-27
ZA9811595B (en) 2000-06-19
US6562861B1 (en) 2003-05-13
ATE425955T1 (de) 2009-04-15
CY1109153T1 (el) 2014-07-02
PT1040094E (pt) 2009-06-03
KR20010024743A (ko) 2001-03-26
DE69840674D1 (de) 2009-04-30
EP1040094B9 (en) 2015-09-09
NO20003084D0 (no) 2000-06-15
AU2200199A (en) 1999-07-19
PL341431A1 (en) 2001-04-09
CY2018023I2 (el) 2018-12-12
CY2018023I1 (el) 2018-12-12

Similar Documents

Publication Publication Date Title
BE2018C032I2 (ja)
ITTO970512A0 (ja)
ITRM970309A0 (ja)
CH0944937H2 (ja)
ITMI971324A0 (ja)
ITUD970074A0 (ja)
IN192464B (ja)
BE2013C047I2 (ja)
BR9701757A (ja)
ITRM970335A0 (ja)
GB9708552D0 (ja)
IN186423B (ja)
IN186457B (ja)
IN189828B (ja)
BR9700653A (ja)
ITRM970384A0 (ja)
ITUD970078A0 (ja)
ITMI971280A0 (ja)
ITMI971483A0 (ja)
ITMI970995A0 (ja)
ITRM970360A0 (ja)
CN3055603S (ja)
CN3056417S (ja)
CN3055389S (ja)
CN3055179S (ja)